Bristol-Myers Squibb Company
BMYNYSEHealthcare● Active
$57.27
+$0.67(+1.18%)
Market Cap$116.9B
P/E Ratio—
52W High$62.89
52W Low$42.52
Bristol-Myers Squibb Company (BMY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BMY · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $48.19B | $48.30B | $45.01B | $46.16B | $46.38B |
| Cost of Revenue | $15.59B | $20.87B | $19.65B | $19.67B | $19.62B |
| Gross Profit | $32.60B | $27.43B | $25.36B | $26.49B | $26.76B |
| Gross Margin %(computed) | 67.65% | 56.80% | 56.34% | 57.39% | 57.69% |
| Operating Expenses | |||||
| R&D Expenses | $9.61B | $9.78B | $9.21B | $9.41B | $9.53B |
| G&A Expenses | $5.66B | $6.37B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $19.91B | $17.77B | $16.89B | $17.22B | $17.22B |
| Operating Income | $12.70B | $9.66B | $8.47B | $9.27B | $9.54B |
| Operating Margin %(computed) | 26.34% | 20.00% | 18.82% | 20.08% | 20.57% |
| Interest Income | $0.30B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $1.51B | $1.95B | $1.17B | $1.23B | $1.33B |
| Income Before Tax | $9.33B | ($8.38B) | $8.44B | $7.71B | $8.10B |
| Income Tax Expense | $2.27B | $0.55B | $0.40B | $1.37B | $1.08B |
| Net Income | $7.05B | ($8.95B) | $8.03B | $6.33B | $6.99B |
| Net Margin %(computed) | 14.63% | -18.53% | 17.83% | 13.71% | 15.08% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.46 | $-4.41 | $3.88 | $2.97 | $3.15 |
| Wtd Avg Shares | 2.04B | 2.03B | 2.07B | 2.13B | 2.22B |
| EBITDA | $14.54B | $3.17B | $19.37B | $19.22B | $20.12B |
| EBITDA Margin %(computed) | 30.18% | 6.56% | 43.03% | 41.64% | 43.37% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Bristol-Myers Squibb Company data
About Bristol-Myers Squibb Company (BMY) Income Statement
Bristol-Myers Squibb Company (BMY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BMY reported revenue of $48.19B, gross profit of $32.60B (gross margin 67.65%), and net income of $7.05B — a net profit margin of 14.63%.
Frequently asked questions
BMY · 4 questionsBristol-Myers Squibb Company (BMY) reported revenue of $48.19B for 2025, down 0.2% year-over-year.
BMY revenueBMY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08